Research and Development

A team of biomedical engineering researches, who performed their study at the University of Arkansas, have identified a drug that …

Researchers at the University of Toronto have developed a new tool which promises to enable the monitoring and profiling of …

GlaxoSmithKline appointed a new area head in Thomas Willemsen to take charge of its China drug business. He succeeds Herve …

Janssen, a part of Johnson & Johnson, and Genmab have announced that their multiple myeloma drug Darzalex (daratumumab) has been …

AstraZeneca’s clinical trial for head and neck cancer had previously been put on partial hold by the FDA due to …

Acorda Therapeutics announced that they were unable to continue development of the drug, dalfampridine, due to lack of efficacy in …

China has used Crispr/Cas9 gene-editing technology to edit the DNA of a human subject, suffering from metastatic lung cancer. This …

While the world is still reeling from the US presidential election results; it’s business as usual for the pharma industry; …

GlaxoSmithKline and Janssen, part of Johnson & Johnson, released the results of their two Phase III trials exploring treatment options …

Japan’s health ministry has announced it is to slash the price of Bristol-Myers Squibb’s Opdivo by 50% in the country …

Amgen released positive results from their second Phase III trial for experimental migraine drug, known as erenumab, which it is …

Shire’s Onivyde has been determined by NICE as not cost effective, in draft guidance, despite adding on average two months …

NICE has announced its approval of Roche’s Perjeta (pertuzumab) as a neoadjuvant treatment of HER2-positive, locally advanced, inflammatory or early-stage …

The myelofibrosis market is expected to grow from $545.2 million in 2015 to $1.02 billion by 2025, almost doubling in …

A study by Boston Children’s Hospital found that parents recognised that placebos are a vital part of research and that …